Your Trusted Source for Research Peptide Information

All content is medically reviewed by Dr. Michael Fortunato, MD, a board-certified anesthesiologist with advanced certification in Bioidentical Hormone Replacement Therapy (BHRT).

Dr. Fortunato specializes in peptide therapy and hormone optimization protocols. Every article is backed by peer-reviewed scientific literature and clinical studies to ensure medical accuracy.

Research peptides are bioactive amino acid chains studied for their therapeutic potential but not yet approved by the FDA for human use. Unlike FDA-approved peptide medications (such as insulin or semaglutide), research peptides are legally designated for laboratory research purposes only.

These compounds are investigated in clinical trials and scientific studies to understand their mechanisms of action, safety profiles, and potential health applications. Many peptides currently classified as “research” compounds show promise in areas like longevity, metabolic health, and tissue repair—but lack the regulatory approval required for prescription use.

Our content educates readers on the existing scientific evidence for these compounds while clearly distinguishing between research applications and FDA-approved therapeutic uses.

Our sole focus is providing accurate, evidence-based education. While many peptide sites rely on anecdotal claims or influencer opinions, we source exclusively from peer-reviewed journals, clinical trials, and vetted academic research. This means you get unbiased information, not sales pitches.

Many peptides discussed on our site are classified as research compounds, meaning they’re intended for laboratory research purposes. We clearly distinguish between FDA-approved peptides and research compounds.

Our content includes safety considerations, potential risks, and contraindications. Always consult a qualified healthcare provider before using any peptide therapy.